Investing
4 Bank of America Strong Buy Growth 10 Stocks That All Pay Dividends
2025-11-10 00:51:47
BofA Securitiesis the investment banking and capital markets division of Bank of America, one of the largest financial institutions in the United States. The division provides a comprehensive range of services, including equity and debt underwriting, mergers and acquisitions advisory, sales and trading, research, and capital markets solutions to corporate, institutional, and government clients worldwide. As a major player on Wall Street, Bank of America Securities competes with other bulge-bracket investment banks and maintains a significant market share across various financial services sectors.-->-->24/7 Wall St. Key Points:With a highly overbought stock market, investors will demand strong earnings to justify the current high valuations.Bank of America’s Growth 10 stocks, which also pay solid dividends, are the ideal pick for growth and income investors now.Dividend-paying stocks are expected to perform well as interest rates continue to decline throughout the rest of the year and into 2026.Are you ahead, or behind on retirement? SmartAsset’s free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don’t waste another minute; learn more here.(Sponsor)-->-->One of ourreaders’ favorite lists is the Growth 10 List, which is a quantitatively generated portfolio of 10 stocks with high expected earnings growth. BofA Global Research analysts select from the most attractive stocks in the S&P 500. Four of the top companies are now outstanding ideas, two of which are in the healthcare sector, which has underperformed this year, and all are rated Buy by Bank of America.Why do we cover Bank of America stocks?BofA Securitiesis one of the top firms on Wall Street, and we have covered the company’s curated stock lists for years. These are the absolute best ideas across several categories, and the firm’s top equity analysts have thoroughly vetted all the stock picks.AllstateLoading stock data...This insurancegiant increased its dividend by 8.7% earlier this year and currently pays a dividend yield of 1.82%. Allstate Corp. (NYSE: ALL) provides property, casualty, and other insurance products in the United States and Canada.It operatesin five segments:Allstate ProtectionRun-off Property-LiabilityProtection ServicesAllstate Health and BenefitsCorporate and otherThe companyoffers private passenger auto, homeowners, personal lines, and commercial insurance products through agents, contact centers, and online, as well as property and casualty insurance. It also provides consumer product protection plans, device and mobile data collection services, and analytic solutions using automotive telematics information, roadside assistance, protection, and insurance products, such as identity protection and restoration through:Allstate Protection PlansAllstate Dealer ServicesAllstate RoadsideArityAllstate Identity Protection brandsIn addition,the company offers life, accident, critical illness, hospital indemnity, short-term disability, and other health insurance products; self-funded stop-loss and fully insured group health products to employers; Medicare supplement, ancillary products, and short-term medical insurance to individuals through independent agents, owned agencies, benefits brokers, and Allstate exclusive agents; and net investment income, net gains on investments, other revenue, debt service, holding company activities, and certain non-insurance operations.The companyalso offers automotive protection, vehicle service contracts, guaranteed asset protection, road hazard tires and wheels, and paintless dent repair protection, as well as roadside assistance, mobility data collection services, and analytical solutions utilizing automotive telematics information. Additionally, it provides identity theft protection and remediation services.BofA Securitieshas a huge $286 target price.Gilead SciencesLoading stock data...Gilead SciencesInc. (NASDAQ: GILD) is a biotech giant that pays a solid 2.77% dividend and offers outstanding total return potential in 2025 and 2026. This biopharmaceutical company discovers, develops, and commercializes medicines for unmet medical needs in the United States, Europe, and elsewhere.The companyprovides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, Sunlens, and Atripla products for the treatment of HIV/AIDS. Additionally, it offers Veklury, an intravenous injection for the treatment of COVID-19, as well as Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis.It also offersYescarta, Tecartus, and Trodelvy products for oncology treatment; Letairis, an oral formulation for treating pulmonary arterial hypertension; and AmBisome, a liposomal formulation for treating serious invasive fungal infections.Gilead Scienceshas collaboration agreements with:Arcus BiosciencesMerck Sharp & DohmePionyr ImmunotherapeuticsTizona TherapeuticsGalapagosJanssen Sciences Ireland UnlimitedJapan TobaccoDragonfly TherapeuticsArcellxEverest MedicinesMerckTentarix BiotherapeuticsMarengo TherapeuticsAssembly BiosciencesIt also hasresearch collaboration, option, and license agreement with Merus to discover novel dual tumor-associated antigens targeting tri-specific antibodies.Bank of Americahas a $140 target price for the shares.MerckLoading stock data...This healthcaregiant is a no-brainer, down over 30% over the past year while paying a solid 3.97% dividend. Merck & Co. Inc. (NYSE: MRK) develops and produces medicines, vaccines, biological therapies, and animal health products. It is not just a healthcare company but a global force in the industry. The company operates through two segments.The Pharmaceuticalsegment offers human health pharmaceutical products in:OncologyHospital acute careImmunologyNeuroscienceVirologyCardiovascularDiabetesVaccine products, such as preventive pediatric, adolescent, and adult vaccinesThe Animal Healthsegment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, health management solutions and services, as well as digitally connected identification, traceability, and monitoring products.Merckserves:Drug wholesalersRetailersHospitalsGovernment agenciesManaged healthcare providers, such as health maintenance organizationsPharmacy benefit managers and other institutionsPhysiciansPhysician distributorsVeterinariansAnimal producersMerck’s growthis a result of its efforts and strategic collaborations. The company works with AstraZeneca, Bayer, Eisai, Ridgeback Biotherapeutics, and Gilead Sciences to jointly develop and commercialize long-acting treatments for HIV, demonstrating a commitment to innovation and growth.Bank of Americahas a target price of $98.TKO GroupLoading stock data...While offthe radar, this sports and entertainment company could prove to be the top Growth 10 idea with a 0.37% dividend. TKO Group Holdings Inc. (NYSE: TKO) owns properties including Ultimate Fighting Championship (UFC), a mixed martial arts organization; World Wrestling Entertainment (WWE), a sports entertainment outfit; and Professional Bull Riders (PBR), a bull riding organization.It alsoservices and partners with sports rights holders through IMG, a global sports marketing agency, and On Location, an experiential hospitality.Its segmentsinclude:UFCWWEIMGThe UFCsegment reflects the business operations of the UFC, which consist of media rights fees associated with the distribution of its programming content, ticket sales, and site fees related to the business’s global live events, as well as partnerships, marketing, and consumer product licensing agreements for UFC-branded products.The WWEsegment reflects the business operations of WWE.The IMG segmentincludes IMG business and On Location. IMG Business is an independent global distributor of sports programming.Bank of Americahas set a $210 target price.Four Stocks That Yield at Least 12% Are Passive Income KingsIf You have $500,000 Saved, Retirement Could Be Closer Than You Think (sponsor)Retirement can be daunting, but it doesn’t need to be. Imagine having an expert in your corner to help you with your financial goals. Someone to help you determine if you’re ahead, behind, or right on track. With SmartAsset, that’s not just a dream—it’s reality. This free tool connects you with pre-screened financial advisors who work in your best interests. It’s quick, it’s easy, so take the leap today and start planning smarter!Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.(sponsor)
read more